Prevalence of Undiagnosed Type-2-Diabetes Mellitus and Impaired Fasting Glucose in German Primary Care: Data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

 

 Buy Article Permissions and Reprints

Abstract

Aims: Primary care physicians are gatekeepers of the healthcare system and thus responsible for screening, prevention and treatment of diabetes. Little is known about the prevalence of diabetes, impaired fasting glucose and factors that are associated with the risk of future development of diabetes and subsequent cardiovascular disease in unselected patients presenting to general practitioners.

Research Design and Methods: A nationwide sample of 35,869 primary care patients screened in 2005 was used to estimate the prevalence of detected and undetected diabetes as well as of impaired fasting glucose. Logistic regressions were used to assess the prevalence, cardiovascular morbidity and the factors associated with undetected diabetes and impaired fasting glucose.

Results: 1) Using a blood glucose screening algorithm the prevalence of known type 1 and type 2 diabetes mellitus was found to be 0.6 and 12.2%, respectively. Another 2.9% (23% of the diagnosed) had either undiagnosed diabetes (0.9%) or impaired fasting glucose (2.0%). 2) Undiagnosed patients had a more unfavourable cardiovascular risk profile compared to non-diabetic patients. 3) Moreover, higher age, male gender, low HDL-cholesterol and elevated triglycerides as well as a family history of diabetes were associated with unknown diabetes or impaired fasting glucose.

Conclusions: Approximately 15.7% of individuals in Germany consulting a primary care physician are affected from either diabetes (known and unknown) or impaired fasting glucose and face a substantially elevated cardiovascular risk score. This study demonstrated that using a simplified blood glucose screening algorithm considering risk markers like higher age, male gender, low HDL-cholesterol, high triglycerides and a family history of diabetes may well serve as a suitable screening approach for undiagnosed diabetes and impaired fasting glucose in primary care practice.

References

• 1 Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition.  Lancet. 2005;  366 1059-1062
  CrossrefPubMedGoogle Scholar
• 2 Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe.  Diabetes Metab. 2000;  26 282-286
  PubMedGoogle Scholar
• 3 Balkau B, Vernay M, Mhamdi L. et al . The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study.  Diabetes Metab. 2003;  29 526-532
  CrossrefPubMedGoogle Scholar
• 4 Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.  Diabetologia. 2004;  47 1566-1573
  CrossrefPubMedGoogle Scholar
• 5 Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.  Lancet. 2006;  368 1651-1659
  CrossrefPubMedGoogle Scholar
• 6 Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions.  Diabetes Care. 2003;  26 575-581
  CrossrefPubMedGoogle Scholar
• 7 Franse LV, Di Bari M, Shorr RI. et al . Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the health, aging, and body composition study.  Diabetes Care. 2001;  24 2065-2070
  CrossrefPubMedGoogle Scholar
• 8 Gaede P, Vedel P, Larsen N. et al . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 383-393
  Google Scholar
• 9 Grundy SM, Cleeman JI, Daniels SR. et al . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.  Circulation. 2005;  112 2735-2752
  CrossrefPubMedGoogle Scholar
• 10 Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.  N Engl J Med. 1998;  339 229-234
  CrossrefPubMedGoogle Scholar
• 11 Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective.  Diabetes Metab Res Rev. 2000;  16 230-236
  PubMedGoogle Scholar
• 12 Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.  Diabetes Care. 1992;  15 815-819
  CrossrefPubMedGoogle Scholar
• 13 Hauner H. Occurrence of diabetes mellitus in Germany.  Dtsch Med Wochenschr. 1998;  123 777-782
  PubMedGoogle Scholar
• 14 Hauner H, Koster I, Ferber L von. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hessen/KV in Hessen.  Dtsch Med Wochenschr. 2003;  128 2632-2637
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Isomaa B, Almgren P, Tuomi T. et al . Cardiovascular morbidity and mortality associated with the metabolic syndrome.  Diabetes Care. 2001;  24 683-689
  CrossrefPubMedGoogle Scholar
• 16 Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care. 2005;  28 2289-2304
  CrossrefPubMedGoogle Scholar
• 17 Krone W, Böhm M. Erhebung und Verbesserung der Behandlungssituation von Patienten mit Diabetes mellitus. Das DUTY-Register.  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;  47 540-546
  PubMedGoogle Scholar
• 18 Lakka HM, Laaksonen DE, Lakka TA. et al . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.  JAMA. 2002;  288 2709-2716
  CrossrefPubMedGoogle Scholar
• 19 Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross sectional population study.  BMJ. 2001;  323 548-551
  CrossrefPubMedGoogle Scholar
• 20 Lehnert H, Wittchen HU, Pittrow D. et al . Prevalence and pharmacotherapy of diabetes mellitus in primary care.  Dtsch Med Wochenschr. 2005;  130 323-328
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes.  Annu Rev Nutr. 2003;  23 345-377
  CrossrefPubMedGoogle Scholar
• 22 Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk.  Diabetes Care. 2003;  26 725-731
  CrossrefPubMedGoogle Scholar
• 23 Löwel H, Stieber J, Koenig W. et al . The diabetes-related risk of myocardial infarction in a southern German population: results of the MONICA Augsburg studies 1985-1994.  Diab Stoffw. 1999;  8 11-21
  PubMedGoogle Scholar
• 24 MacAuley KA, Williams SM, Mann JI. et al . Diagnosing insulin resistance in the general population.  Diabetes Care. 2001;  24 460-464
  CrossrefPubMedGoogle Scholar
• 25 Moebus S, Hanisch JU, Neuhäuser M. et al . Assessing the Metabolic Syndrome according to NCEP ATP III in Germany: Feasibility of a two step approach in 1 550 randomly selected primary health care practices.  GMS. 2006;  4 , Doc7 (20061009)
  PubMedGoogle Scholar
• 26 Pittrow D, Stalla GK, Zeiher AM. et al . Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care.  Med Klin (Munich). 2006;  101 635-644
  CrossrefPubMedGoogle Scholar
• 27 Rathmann W, Haastert B, Icks A. et al . High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening.  The KORA survey 2000. , Diabetologia 2003;  46 182-189
  CrossrefPubMedGoogle Scholar
• 28 SAS9.1 .>In. Release 9.1 ed. Cary NC: SAS Institute Inc. 2005
• 29 Sattar N, Gaw A, Scherbakova O. et al . Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.  Circulation. 2003;  108 414-419
  CrossrefPubMedGoogle Scholar
• 30 Scherbaum WA, Dicken HD, Verheyen F, Baehring T. Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening.  Dtsch Med Wochenschr. 2006;  131 2208-2212
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Schulze J, Rothe U, Muller G, Kunath H. Improvement of care for diabetics using the care model from Saxony.  Dtsch Med Wochenschr. 2003;  128 1161-1166
  Article in Thieme ConnectPubMedGoogle Scholar
• 32 Thefeld W. Prevalence of diabetes mellitus in the adult German population.  Gesundheitswesen. 1999;  61 , Spec No:S85-89
  PubMedGoogle Scholar
• 33 UKPDS . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  BMJ. 1998;  317 703-713
  PubMedGoogle Scholar
• 34 UKPDS. . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).  Lancet. 1998;  352 837-853
  CrossrefPubMedGoogle Scholar
• 35 Uusitupa M, Siitonen O, Aro A, Pyorala K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.  Diabetologia. 1985;  28 22-27
  CrossrefPubMedGoogle Scholar
• 36 Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.  BMJ. 2001;  322 986-988
  CrossrefPubMedGoogle Scholar
• 37 WHO . Definition, diagnosis and classification of diabetes mellitus and its complications.  , Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus 1999; 
  Google Scholar

Correspondence

Prof. H. HaunerMD 

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin

Technical University Munich

Klinikum rechts der Isar

Ismaninger Str. 22

81675 München

Phone: +49/89/4140 67 71

Fax: +49/89/4140 67 72

Email: hans.hauner@lrz.tu-muenchen.de